Deferred Tax Assets, Valuation Allowance in USD of LIXTE BIOTECHNOLOGY HOLDINGS, INC. from Q4 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
LIXTE BIOTECHNOLOGY HOLDINGS, INC. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2011 to Q4 2024.
  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $12,617,000, a 7.9% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

LIXTE BIOTECHNOLOGY HOLDINGS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $12,617,000 +$929,000 +7.9% 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q4 2023 $11,688,000 +$842,000 +7.8% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q4 2022 $10,846,000 +$1,851,000 +21% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q4 2021 $8,995,000 +$2,016,000 +29% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q4 2020 $6,979,000 +$932,000 +15% 31 Dec 2020 10-K 21 Mar 2022 2021 FY
Q4 2019 $6,047,000 +$661,000 +12% 31 Dec 2019 10-K 26 Mar 2021 2020 FY
Q4 2018 $5,386,000 +$624,000 +13% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q4 2017 $4,762,000 -$1,532,000 -24% 31 Dec 2017 10-K 25 Mar 2019 2018 FY
Q4 2016 $6,294,000 +$605,000 +11% 31 Dec 2016 10-K 23 Mar 2018 2017 FY
Q4 2015 $5,689,000 +$986,000 +21% 31 Dec 2015 10-K 29 Mar 2017 2016 FY
Q4 2014 $4,703,000 +$832,000 +21% 31 Dec 2014 10-K 28 Mar 2016 2015 FY
Q4 2013 $3,871,000 +$1,288,000 +50% 31 Dec 2013 10-K 27 Mar 2015 2014 FY
Q4 2012 $2,583,000 +$571,000 +28% 31 Dec 2012 10-K 21 Mar 2014 2013 FY
Q4 2011 $2,012,000 31 Dec 2011 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.